At a glance: Departmental Evaluation Plan for the Public Health Agency of Canada, 2023-24 to 2027-28

The OAE Departmental Evaluation Plan for Public Health Agency of Canada (PHAC) describes the Program Evaluation Division's scheduled work for the five-year period from 2023-24 to 2027-28. The Plan was developed to meet PHAC's commitments under the Policy on Results (2016), which requires that each department prepare a five-year plan, updated annually.

The projects included in this Evaluation Plan were selected to ensure full coverage of all Grants and Contributions spending over $5 million annually over a five-year period, and that prior commitments in Treasury Board (TB) submissions were met, as well as addressing the information needs of program management, coverage of program risks, and optimal use of resources. The Departmental Results Framework (DRF), program inventory, and performance information profiles developed by PHAC have formed the basis for this plan.

With COVID-19 no longer considered a global health emergency, PHAC's work has shifted focus to its ongoing program activities. As such, the present Departmental Evaluation Plan (DEP) ensures that the Office of Audit and Evaluation (OAE) continues to meet its reporting commitments under the Financial Administration Act (FAA) and any Treasury Board (TB) submission commitments, while also addressing key risks and senior management and program management information needs. Given the importance of the COVID-19 response, the impact of the pandemic on PHAC activities will continue to be assessed in most evaluations in the DEP, notably in the area of data modernization, border and travel health, and emergency preparedness and response.

Planning for evaluation

Over the next five years, OAE plans to conduct 35 evaluations that involve PHAC: 25 will focus exclusively on PHAC activities, and one evaluation will examine the activities of both PHAC and Health Canada. The remaining nine projects are horizontal evaluations led by other government departments or agencies. A yearly breakdown is provided in Table 1. Table 2 outlines the direct program spending (DPS) by core responsibility for all scheduled evaluations for the next five years.

Table 1 – Number of evaluations per fiscal year
Lead 2023-24 2024-25 2025-26 2026-27 2027-28 Total
PHAC 4 5 6 6 4 25
PHAC and HC 0 0 1 0 0 1
Horizontal (OGD-led) 1 1 1 1 5 9
Total 5 6 8 7 9 35

Table 2 – Coverage of direct program spending (DPS)

Table 2 – Coverage of direct program spending (DPS)
Program Evaluations planned in the next five years Fiscal year of approval 2023-24 spending covered by evaluation ($)Footnote 1 Rationale for not evaluating program or spending
Core Responsibility Health Promotion and Chronic Disease Prevention ($406,889,035)
Health Promotion ($301,225,679) Indigenous Early Learning and Child Care Initiative 2023-24 $29,511,259 N/A
Aging, Seniors and Dementia 2023-24 $16,247,549 N/A
Nutrition North Canada 2024-25 $335,000 N/A
Preventing Gender-Based Violence: the Health Perspective (formerly Supporting the Health of Survivors of Family Violence) 2024-25 $6,250,000 N/A
PHAC's Mental Health Activities 2025-26 $89,567,043 N/A
Maternal and Child Health Programs 2025-26 $98,811,943 N/A
Aboriginal Head Start in Urban and Northern Communities 2027-28
$33,347,831
N/A
Fetal Alcohol Spectrum Disorder (FASD) and Autism Spectrum Disorder (ASD) Initiatives 2027-28 $776,780 N/A
Action Plan for Official Languages 2027-28 $2,088,475 N/A
Horizontal Evaluation of the Legalization and Regulation of Cannabis 2027-28 $651,337 N/A
Impact Assessment and Regulatory Processes (IARP) Horizontal Initiative 2027-28 $400,000 N/A
National Action Plan on Violence Against Women and Gender-Based Violence 2027-28 $12,238,462 N/A
Contribution Funding for the Centre for Aging and Brain Health Innovation (CABHI) N/A $11,000,000 The timing for the evaluation will be determined during the development of a future Departmental Evaluation Plan. It was recently evaluated in 2019-20.
Chronic Disease Prevention ($34,693,013) Public Health Agency of Canada's (PHAC) Funding of ParticipACTION's Let's Get Moving Initiative 2023-24 $0 N/A
Healthy Canadians and Communities Fund 2025-26 $27,784,076 N/A
Health Portfolio's Tobacco and Vaping Activities 2025-26 $205,000 N/A
Office of International Affairs 2025-26 $0 N/A
Type 2 Diabetes Prevention Challenge N/A $4,935,000 This is a time limited contribution (Start Date: 2021-22 – End Date: 2023-24) with low materiality
Development of a National Diabetes Framework N/A $1,768,937 This is a time limited contribution (Start Date: 2021-22 - End Date: 2025-26) with low materiality.
Evidence for Health Promotion, and Chronic Disease and Injury Prevention ($70,970,343) Aging, Seniors and Dementia 2023-24 $1,986,564 N/A
National Collaborating Centres 2023-24 $2,921,002 N/A
Nutrition North Canada 2024-25 $50,000 N/A
PHAC's Mental Health Activities 2025-26 $1,734,219 N/A
Healthy Canadians and Communities Fund 2025-26 $1,333,000 N/A
Evidence for Health Promotion Chronic Disease and Injury Prevention 2026-27 $38,291,072 N/A
Office of the Chief Dental Officer 2026-27 $567,827 N/A
Horizontal Evaluation of the Canadian Drug and Substance Strategy (Including the overdose crisis in Canada) 2027-28 $1,545,658 N/A
Fetal Alcohol Spectrum Disorder (FASD) and Autism Spectrum Disorder (ASD) Initiatives 2027-28 $1,499,000 N/A
National Action Plan on Violence Against Women and Gender-Based Violence 2027-28 $241,543 N/A
Pan-Canadian Joint Consortium for School Health N/A $250,000 This funding doesn't fit with other children's programs and has very low materiality.
Post COVID-19 Condition N/A $20,550,458 The timing for the evaluation will be determined during the development of a future Departmental Evaluation Plan.
Core Responsibility Infectious Diseases Prevention and Control ($3,356,032,806)
Laboratory Science Leadership and Services ($175,242,596) Sexually Transmitted and Blood-Borne Infections 2023-24 $6,225,772 N/A
Emergency Preparedness and Response 2024-25 $74,016,531 N/A
Data Modernization 2024-25 $44,110,560 N/A
Genomics Research and Development Initiative (GRDI) 2025-26 $2,304,596 N/A
Infectious Disease and Climate Change 2025-26 $1,116,689 N/A
Adapting to Impacts of Climate Change (Roll-up of Departmental Evaluation) 2026-27 $0 N/A
Medical Countermeasures Capacity 2026-27 $45,086,880 N/A
Food-borne and Water-borne Enteric Diseases 2027-28 $1,921,568 N/A
Public Health Scholarship and Capacity Building Initiative (PHSCBI) N/A $460,000 The timing for the evaluation will be determined during the development of a future Departmental Evaluation Plan.
Communicable Diseases and Infection Control ($90,243,807) Sexually Transmitted and Blood-Borne Infections 2023-24 $34,244,000 N/A
National Collaborating Centres 2023-24 $973,666 N/A
Emergency Preparedness and Response 2024-25 $43,157,944 N/A
Health Care-Associated Infections 2026-27 $2,678,197 N/A
Tuberculosis 2026-27 $0 N/A
Horizontal Evaluation of the Canadian Drug and Substance Strategy (Including the overdose crisis in Canada) 2027-28 $7,000,000 N/A
PHAC Blood Safety Program 2027-28 $2,190,000 N/A
Immunization and Vaccine Preventable Disease
($3,071,452,799)
Immunization and Respiratory Infectious Diseases 2024-25 $3,005,702,799 N/A
Sero-Surveillance Consortium 2024-25 $65,500,000 N/A
COVID-19 Individual Risk Assessment Tool N/A $250,000 This is a time limited contribution (Start Date: June 25, 2021- End Date: March 31, 2023) with low materiality.
Foodborne and Zoonotic Disease
($19,093,604)
National Collaborating Centres 2023-24 $973,666 N/A
Emergency Preparedness and Response 2024-25 $7,637,668 N/A
Office of International Affairs 2025-26 $0 N/A
Infectious Disease and Climate Change 2025-26 $5,385,652 N/A
Genomics Research and Development Initiative (GRDI) 2025-26 $1,470,317 N/A
Adapting to Impacts of Climate Change (Roll-up of Departmental Evaluation) 2026-27 $0 N/A
Food-borne and Water-borne Enteric Diseases 2027-28 $3,626,301 N/A
Core Responsibility Health Security ($299,710,417)
Emergency Preparedness and Response ($284,127,084) National Collaborating Centres 2023-24 $973,666 N/A
Emergency Preparedness and Response 2024-25 $282,746,624 N/A
Biosecurity Program 2025-26 $319,623 N/A
Food-borne and Water-borne Enteric Diseases 2027-28 $87,171 N/A
Biosecurity
($8,723,072)
Biosecurity Program 2025-26 $8,723,072 N/A
Border Health Security
($6,860,261)
Biosecurity Program 2025-26 $90,539 N/A
Border and Travel Health Program 2026-27 $6,769,722 N/A

Footnotes

Footnote 1

To obtain detailed estimates on program budgets, annual data for 2023-24 is presented. This financial data was extracted by the Office of the Chief Financial Officer on March 21, 2023. As a result, these budget figures may not fully align with those contained in other corporate reporting documents such as the Departmental Plan, the Departmental Results Report, or the Three-Year Transfer Payment Program Plan.

Return to footnote 1 referrer

Page details

Date modified: